Guru Ownership Trend
Guru Analysis for Sarepta Therapeutics (SRPT)
Sarepta Therapeutics (SRPT), a key player in the 醫療健康 sector, continues to attract institutional attention.
As of Q3 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.49 B.
Top institutional holders include 保羅·都鐸·瓊斯 and 文藝復興科技.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $133.32 M net inflow during the quarter.
Recent activity highlights 保羅·都鐸·瓊斯 who dramatically increased their stake.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 0.11% | Add 135261.8% | 68,832,803 | $63.35 M | Q3 2025 | |
| 0.07% | Add 324.4% | 2,650,178 | $51.07 M | Q3 2025 | |
| 0.02% | Add 1015.8% | 1,405,675 | $26.4 M | Q3 2025 | |
| 0.03% | New Buy | 352,275 | $6.79 M | Q3 2025 | |
| 0.35% | Add 33.3% | 84,000 | $1.62 M | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Sarepta Therapeutics (SRPT)
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $133.32 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited SRPT. The total reported sell value was $239,024.
Yes, 1 managers opened new positions in SRPT, and 4 increased their existing holdings. The total reported buy value was $133.56 M.